| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), LGND's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $46.37M | - | |
| Dir | 43.7K | $12.56M | - | |
| CFO | 28.6K | $8.21M | - | |
| Dir | 11.7K | $3.35M | - | |
| Dir | 4.4K | $1.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2015 | Foehr Matthew W72 | President And COO | Sale+OE | 12,500 | $100.97 | $1,262,125.00 | -15.1% | |
| Jun 22, 2015 | Foehr Matthew W72 | President And COO | Sale+OE | 23,046 | $96.45 | $2,222,814.62 | -9.2% | |
| Jun 10, 2015 | Herman Melanie J | Interim CFO | Sale+OE | 4,125 | $93.50 | $385,687.50 | -58.0% | |
| Jun 9, 2015 | Higgins John L66 | Chief Executive Officer | Sell | 10,000 | $92.88 | $928,809.00 | -2.5% | |
| Jun 4, 2015 | Aryeh Jason | Director | Sell | 1,640 | $92.68 | $151,995.20 | -0.7% | |
| May 20, 2015 | Aryeh Jason | Director | Sell | 9,240 | $87.34 | $807,046.80 | -1.2% | |
| May 14, 2015 | Desilva Nishan M | VP, Finance &Strategy And CFO | Sale+OE | 68,363 | $83.91 | $5,736,515.82 | -38.0% | |
| Mar 19, 2015 | Patel Sunil | Director | Sell | 4,591 | $74.42 | $341,662.22 | -11.0% | |
| Mar 16, 2015 | Berkman Charles S81 | VP, Gen. Counsel &Secretary | Sale+OE | 11,264 | $74.54 | $839,649.12 | -12.6% | |
| Mar 2, 2015 | Herman Melanie J | Director Of Accounting | Sell | 535 | $60.69 | $32,469.15 | -15.2% |